These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1254 related articles for article (PubMed ID: 28652656)

  • 121. Correlation of clinical and endoscopic indices in IBD patients in University Clinical Hospital Mostar.
    Babić E; Bevanda M; Karin M; Volarić M; Bevanda D; Glibo DB; Bogut A
    Psychiatr Danub; 2016 Dec; 28 Suppl 2():242-246. PubMed ID: 28035129
    [TBL] [Abstract][Full Text] [Related]  

  • 122. [Diagnostic problems of histological remission in patients with inflammatory bowel disease].
    Tertychnyi AS; Akhrieva KM; Maev IV; Zayratyants OV; Selivanova LS
    Arkh Patol; 2017; 79(3):3-9. PubMed ID: 28631710
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Reduced hydrophobicity of the colonic mucosal surface in ulcerative colitis as a hint at a physicochemical barrier defect.
    Braun A; Schönfeld U; Welsch T; Kadmon M; Funke B; Gotthardt D; Zahn A; Autschbach F; Kienle P; Zharnikov M; Grunze M; Stremmel W; Ehehalt R
    Int J Colorectal Dis; 2011 Aug; 26(8):989-98. PubMed ID: 21455745
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases.
    Ungar B; Levy I; Yavne Y; Yavzori M; Picard O; Fudim E; Loebstein R; Chowers Y; Eliakim R; Kopylov U; Ben-Horin S
    Clin Gastroenterol Hepatol; 2016 Apr; 14(4):550-557.e2. PubMed ID: 26538204
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Persistent Diarrhea in Patients With Crohn's Disease After Mucosal Healing Is Associated With Lower Diversity of the Intestinal Microbiome and Increased Dysbiosis.
    Boland K; Bedrani L; Turpin W; Kabakchiev B; Stempak J; Borowski K; Nguyen G; Steinhart AH; Smith MI; Croitoru K; Silverberg MS
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):296-304.e3. PubMed ID: 32220613
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Performance of Common Disease Activity Markers as a Reflection of Inflammatory Burden in Ulcerative Colitis.
    Brandse JF; Bennink RJ; van Eeden S; Löwenberg M; van den Brink GR; DʼHaens GR
    Inflamm Bowel Dis; 2016 Jun; 22(6):1384-90. PubMed ID: 26978724
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Melanocortin 3,5 receptors immunohistochemical expression in colonic mucosa of inflammatory bowel disease patients: A matter of disease activity?
    Gravina AG; Panarese I; Trotta MC; D'Amico M; Pellegrino R; Ferraraccio F; Galdiero M; Alfano R; Grieco P; Federico A
    World J Gastroenterol; 2024 Mar; 30(9):1132-1142. PubMed ID: 38577176
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Peripheral Lymphocytes of Patients with Inflammatory Bowel Disease Have Altered Concentrations of Key Apoptosis Players: Preliminary Results.
    Neubauer K; Woźniak-Stolarska B; Krzystek-Korpacka M
    Biomed Res Int; 2018; 2018():4961753. PubMed ID: 30515402
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Vascular endothelial growth factor, endostatin levels and clinical features among patients with ulcerative colitis and irritable bowel syndrome and among healthy controls: a cross-sectional analytical study.
    Aksoy EK; Çetinkaya H; Savaş B; Ensari A; Torgutalp M; Efe C
    Sao Paulo Med J; 2018; 136(6):543-550. PubMed ID: 30892485
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Vitamin D deficiency associated with Crohn's disease and ulcerative colitis: a meta-analysis of 55 observational studies.
    Li XX; Liu Y; Luo J; Huang ZD; Zhang C; Fu Y
    J Transl Med; 2019 Sep; 17(1):323. PubMed ID: 31547829
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Serum galectins as potential biomarkers of inflammatory bowel diseases.
    Yu TB; Dodd S; Yu LG; Subramanian S
    PLoS One; 2020; 15(1):e0227306. PubMed ID: 31929564
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.
    Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H
    Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients.
    Rouiller-Braunschweig C; Fournier N; Pittet V; Dudler J; Michetti P
    Digestion; 2017 Nov; 96(4):220-227. PubMed ID: 29065423
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease.
    Ludwiczek O; Vannier E; Borggraefe I; Kaser A; Siegmund B; Dinarello CA; Tilg H
    Clin Exp Immunol; 2004 Nov; 138(2):323-9. PubMed ID: 15498044
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Heat shock transcription factor 2 predicts mucosal healing and promotes mucosal repair of ulcerative colitis.
    Wen Y; Niu J; Zhang F; Wu J; Li M; Sun Y; Wang W; Xia S; Tan Y; Wang K; Miao Y
    Scand J Gastroenterol; 2020 Jun; 55(6):677-686. PubMed ID: 32538201
    [No Abstract]   [Full Text] [Related]  

  • 136. Serum adipokines in inflammatory bowel disease.
    Waluga M; Hartleb M; Boryczka G; Kukla M; Zwirska-Korczala K
    World J Gastroenterol; 2014 Jun; 20(22):6912-7. PubMed ID: 24944482
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Physician global assessments or blood tests do not predict mucosal healing in ulcerative colitis.
    Brahmania M; Bernstein CN
    Can J Gastroenterol Hepatol; 2014 Jun; 28(6):325-9. PubMed ID: 24945187
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease.
    Al-Bawardy B; Ramos GP; Willrich MAV; Jenkins SM; Park SH; Aniwan S; Schoenoff SA; Bruining DH; Papadakis KA; Raffals L; Tremaine WJ; Loftus EV
    Inflamm Bowel Dis; 2019 Feb; 25(3):580-586. PubMed ID: 30165638
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Impaired erythrocyte antioxidant defense in active inflammatory bowel disease: impact of anemia and treatment.
    Krzystek-Korpacka M; Neubauer K; Berdowska I; Zielinski B; Paradowski L; Gamian A
    Inflamm Bowel Dis; 2010 Sep; 16(9):1467-75. PubMed ID: 20186929
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease.
    Weigert J; Obermeier F; Neumeier M; Wanninger J; Filarsky M; Bauer S; Aslanidis C; Rogler G; Ott C; Schäffler A; Schölmerich J; Buechler C
    Inflamm Bowel Dis; 2010 Apr; 16(4):630-7. PubMed ID: 19714754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.